Photodynamic therapy in the anti-VEGF era
Open Access
- 17 May 2007
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 91 (6) , 707-708
- https://doi.org/10.1136/bjo.2007.114041
Abstract
An insight as to how photodynamic therapy might play a role in new therapeutic armamentariumKeywords
This publication has 14 references indexed in Scilit:
- Recurrence of choroidal neovascularisation after photodynamic therapy in patients with age-related macular degenerationBritish Journal of Ophthalmology, 2007
- INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- Ranibizumab for Treatment of Neovascular Age-Related Macular DegenerationOphthalmology, 2006
- VEGF as a Therapeutic Target in CancerOncology, 2005
- Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2005
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE) IN PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES: UPDATERetina, 2005
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.1999
- MULTIPLE COMPARISON PROCEDURES UPDATEDClinical and Experimental Pharmacology and Physiology, 1998
- Photosensitizers in photodynamic therapy.1994